Xbrane Biopharma AB's total assets for Q3 2025 were kr701.48M, an increase of 16.56% from the previous quarter. SE:XBRANE total liabilities were kr114.43M for the fiscal quarter, a -47.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.